Asthma treatment study for people using high-dose inhalers
Part of Lungs & breathing clinical trials.
This study tests if a treatment plan called GDMT can help people whose asthma is not well controlled even with high-dose inhaled steroids and long-acting bronchodilators. It is for adults who have had at least one asthma flare-up in the past year.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have had asthma for more than 6 months and have proof that your airways are reversible (like a breathing test shows improvement after medicine).
- You currently use a high or medium dose of inhaled steroids combined with a long-acting bronchodilator.
- You have had one or more asthma attacks in the past year that required steroids, an ER visit, or a hospital stay.
- You have never been diagnosed with 'severe asthma' or used asthma biologic medicines.
- You have no recent lung infections or other major health conditions that would make the study unsafe for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental drug called 610 for people with severe asthma that is not well-controlled with standard medicines. The goal is to see if adding 610 can improve asthma control and reduce flare-ups.
This trial tests whether stepping up to either a higher dose of inhaled steroid/long-acting bronchodilator or a special fine-particle triple therapy (which includes an extra medication) can improve small-airway health in people whose asthma is still not well controlled on a medium-dose combination.
This trial studies how stepping up asthma treatment affects asthma control in people with mild to moderate asthma. You may be asked to use study inhalers correctly and track symptoms and lung tests to see if control improves.
This study is testing an investigational medication for people with uncontrolled asthma. Participants must have moderate-to-severe asthma, be on appropriate maintenance therapy, and meet specific safety criteria.
This trial tests a new drug called MG-K10 for people with moderate to severe asthma that is not well controlled with current treatments. It aims to see if the drug can reduce asthma attacks and improve breathing. You may be able to join if you have had asthma for at least a year, use high-dose inhalers plus another controller medicine, and have had a recent flare-up.
This trial tests an add-on medicine called GB-0895 for people with severe asthma that is not well controlled with current treatments. It aims to see if adding this drug can reduce asthma attacks and improve breathing.
Hear when a new Uncontrolled Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.